Has There Been Exacerbation of Disparities in Antimicrobial Resistance during the SARS-Cov-2 Pandemic?

Evans L , Rhodes A , Alhazzani W , et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med, 2021; 49(11):e1063–e1143; doi: 10.1097/CCM.0000000000005337.

Anderson DJ , Podgorny K , Berríos-Torres SI , et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol, 2014; 35(Suppl 2):S66–S88; doi: 10.1017/s0899823x00193869.

Bratzler DW , Dellinger EP , Olsen KM , et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect, 2013; 14(1):73–156; doi: 10.1089/sur.2013.9999.

World Health Organization. Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline, Including Tuberculosis. Geneva: World Health Organization; 2017. WHO/EMP/IAU/2017.11.

World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. Geneva: World Health Organization; 2014.

Weiner-Lastinger LM , Pattabiraman V , Konnor RY , et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol, 2022; 43(1):12–25; doi: 10.1017/ice.2021.362.

Maes M , Higginson E , Pereira-Dias J , et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit Care 2021;25(1):25; doi: 10.1186/s13054-021-03460-5.

Ripa M , Galli L , Poli A , et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect, 2021; 27(3):451–457; doi: 10.1016/j.cmi.2020.10.021.

Saini V , Jain C , Singh NP , et al. Paradigm shift in antimicrobial resistance pattern of bacterial isolates during the COVID-19 pandemic. Antibiotics (Basel) 2021;10(8)::954; doi: 10.3390/antibiotics10080954.

Ashiru-Oredope D , Kerr F , Hughes S , et al. Assessing the impact of COVID-19 on antimicrobial stewardship activities/programs in the United Kingdom. Antibiotics (Basel) Jan 23 2021;10(2):110; doi: 10.3390/antibiotics10020110.

Tomczyk S , Taylor A , Brown A , et al. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: A global survey. J Antimicrob Chemother, 2021; 76(11):3045–3058; doi: 10.1093/jac/dkab300.

Wang H , Yu X , Zhou H , et al. Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010–2016: a retrospective observational study. BMJ Open 2019;9(8):e026072; doi: 10.1136/bmjopen-2018-026072.

Adebisi YA , Alaran AJ , Okereke M , et al. COVID-19 and antimicrobial resistance: A review. Infect Dis (Auckl) 2021;14:11786337211033870; doi: 10.1177/11786337211033870.

Lucien MAB , Canarie MF , Kilgore PE , et al. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings. Int J Infect Dis, 2021; 104:250–254; doi: 10.1016/j.ijid.2020.12.087.